The DOI matches its Crossref record; 26 of the 27 references it cites were found in a registry or an index.
Obesity, insulin resistance, and type 1 diabetes mellitus
Abstract
PURPOSE OF REVIEW: To summarize recent studies about obesity, insulin resistance, and type 1 diabetes mellitus (T1DM). RECENT FINDINGS: Overweight and obesity continue to be prevalent among individuals with T1DM. Obesity rates appear to have reached a plateau among children with T1DM in some parts of the world. The risk for development of T1DM is increased by obesity and may occur at an earlier age among obese individuals with a predisposition. Obesity increases the risk for comorbidities among individuals with T1DM, especially metabolic syndrome, and microvascular and macrovascular diseases. Metformin, glucagon-like peptide-1 agonist therapy, sodium glucose cotransporter-2 inhibitor therapy, and bariatric surgery may be beneficial therapies for glucose control, comorbidity management, and obesity among adults with T1DM. Insulin resistance may be improved among obese individuals with T1DM by biguanides (metformin) and glucagon-like peptide-1 agonists (exenatide). SUMMARY: We review the last 18 months of literature on obesity, insulin resistance, and T1DM to highlight new epidemiologic results and treatments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, there are multiple factors, particular obesity, increase the levels of adipocytes, inflammatory cytokines (IL-1, IL-6, and TNFα) (91).”
From Diabetes and Sarcopenic Obesity: Pathogenesis, Diagnosis, and Treatments (2020) · cites this paper as [91]
Citations
Cites
Obesity in autoimmune diseases: Not a passive bystander
Versini, M., Jeandel, P.-Y., Rosenthal, E., & Shoenfeld, Y. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.07.001 · Cited by 694
The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes
Wilkin, T. J. (2001) · Diabetologia · doi:10.1007/s001250100548 · Cited by 623
Liu, L. L., Lawrence, J. M., Davis, C., Liese, A. D., Pettitt, D. J., Pihoker, C., Dabelea, D., Hamman, R. F., Waitzfelder, B., Kahn, H. S., et al. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00519.x · Cited by 404
Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort
Harpsøe, M. C., Basit, S., Andersson, M., Nielsen, N. M., Frisch, M., Wohlfahrt, J., Nohr, E. A., Linneberg, A. R., & Jess, T. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu045 · Cited by 248
Perkins, B. A., Cherney, D. Z. I., Partridge, H., Soleymanlou, N., Menezes, H. T., Zinman, B., Fagan, N. M., Kaspers, S., Woerle, H., Broedl, U. C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-2338 · Cited by 232
The use of metformin in type 1 diabetes: a systematic review of efficacy
Vella, S., Buetow, L., Royle, P., Livingstone, S., Colhoun, H. M., & Petrie, J. R. (2010) · Diabetologia · doi:10.1007/s00125-009-1636-9 · Cited by 201
Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis
Dahlquist, G. G. (2005) · Diabetologia · doi:10.1007/s00125-005-0076-4 · Cited by 197
Type 1 diabetes, metabolic syndrome and cardiovascular risk
Chillarón, J. J., Flores Le-Roux, J. A., Benaiges, D., & Pedro-Botet, J. (2014) · Metabolism · doi:10.1016/j.metabol.2013.10.002 · Cited by 195
Metformin: Effects on Micro and Macrovascular Complications in Type 2 Diabetes
Bailey, C. J. (2008) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-008-6092-0 · Cited by 138
Fröhlich-Reiterer, E. E., Rosenbauer, J., Pozza, S. B., Hofer, S. E., Schober, E., Holl, R. W., & on behalf of the DPV-Wiss Study Group and the German BMBF Competence Networks Diabetes mellitus and Obesity (2014) · Archives of Disease in Childhood · doi:10.1136/archdischild-2013-304237 · Cited by 128
Cited by
Sorted by citations
Items 201–232 of 232
Iron status in diabetes mellitus
Daoud, A. G., Jaber, H., & Abdalah, M. E. (2019) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v19i3.562
Pesticides and Risk of Obesity and Diabetes
(2018) · Journal of Community Medicine & Public Health · doi:10.29011/2577-2228.100031
Baş, M. T., Molu, B., & Bükülmez, A. (2019) · DergiPark (Istanbul University)
Vastyanov, R. S., Чехлова, О. В., & Chekhlov, M. V. (2020) · Medical and Clinical Chemistry · doi:10.11603/mcch.2410-681x.2020.v.i1.11058
Severeyn, É., Cruz, A. L., Wong, S., & Perpiñán, G. (2020) · Advances in intelligent systems and computing · doi:10.1007/978-3-030-63665-4_13
The Double Whammy of Obesity and Diabetes on Female Reproductive Health
Thong, E. P., & Burden, C. (2020) · Seminars in Reproductive Medicine · doi:10.1055/s-0041-1723777 · Cited by 2
What Is the Optimal Family Size for a Minimal Likelihood of Obesity?
Arbel, Y., Fialkoff, C., & Kerner, A. (2021) · Contemporary Jewry · doi:10.1007/s12397-021-09369-z
Rebesco, D. B., de Souza, W. C., de Lima, V. A., Leite, N., Nesi-França, S., Furmann, M., Machado‐Rodrigues, A. M., Smolarek, A. D. C., & Mascarenhas, L. P. G. (2019) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · doi:10.1590/1980-0037.2019v2155915
Mediators in cardiovascular disease: association with Raynaud’s phenomenon
Abdulle, A. E. (2021) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.194678419
The effect of metabolic syndrome and its components in midpregnancy on neonatal outcomes
Sourinejad, H., Shayan, A., niyati, S., & Moghaddam‐Banaem, L. (2019) · Medical Journal of the Islamic Republic of Iran · doi:10.47176/mjiri.33.147
HbA1C as a potential Biomarker of Non-Alcoholic Fatty Liver Disease: comparison with BMI, WHR and WCPreprint
Masroor, M., & Haque, Z. (2019) · doi:10.21203/rs.2.12789/v1
Clinical practice guidelines update 2022: Focus on diabetes
Cornell, S. A. (2022) · Pharmacy Today · doi:10.1016/j.ptdy.2022.05.022
Elhabashy, S. A., Elbarbary, N. S., Hassan, A. A., & Thabet, R. A. (2022) · Research Square · doi:10.21203/rs.3.rs-2011231/v1
The Impact of the Hypercaloric Diet versus the Mediterranean Diet on Insulin Sensitivity
Radu, F. I., Ranetti, A.-E., Vasile, M., Sirbu, A. M., Axelerad, A. D., & Sîrbu, C. A. (2023) · Romanian Journal of Military Medicine · doi:10.55453/rjmm.2023.126.3.6 · Cited by 1
Othman, L. B., Alamri, A., Assiri, Y. M., & Alzahrani, F. (2023) · Medical Science · doi:10.54905/disssi/v27i136/e277ms3042
Dietary Management of Diabetes
Guess, N. D. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch27
Heald, A. H., & Krentz, A. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91707-0.00017-6
Lebedev, M. V., Kuznetsova, N. K., Талызин, А. М., Korotkova, E. A., & Zhuravel, S. V. (2024) · Transplantologiya The Russian Journal of Transplantation · doi:10.23873/2074-0506-2024-16-1-88-98
Pavlidou, E., Fasoulas, A., Petridis, D., Tryfonos, C., & Giaginis, C. (2023) · Austin Journal of Nutrition and Food sciences · doi:10.26420/austinjnutrifoodsci.2023.1170
Chen, Y., Kassam, I., Lau, S. H., Kooner, J. S., Wilson, R., Peters, A., Winkelmann, J., Chambers, J. C., Chow, V. T. K., Khor, C. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16841289
Progress in the Clinical Diagnosis and Treatment of Type 1 Diabetes Mellitus
雒, 洋. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441253
Alaei, M., Godazandeh, F., Taghavi, M. S., Zarch, M. V., & Hashemi, M. G. (2024) · Iranian Journal of Radiology · doi:10.5812/ijradiol-145439
Diabetes mellitus doble. Doble desafío para la prescripción de ejercicio. Revisión sistemática
Gittermann, L. M. T., & Astrid von Oetinger, G. (2024) · Rehabilitación · doi:10.1016/j.rh.2024.100866
Csuka, S. I., Horvát, B., Csordás, G., Lakatos, C., & Martos, T. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1455261
Tabagh, R. M. (2025) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.258220
Neurovascular and cognitive damages of diabetes mellitus to the central nervous system
He, F., & He, C.-Y. (2025) · New medicine. · doi:10.61958/nmzb4490
Narcolepsy and metabolic rate: what do we know?
Dhafar, H. O., & BaHammam, A. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30004-2.00016-x
Chen, Y., Kassam, I., Lau, S. H., Kooner, J. S., Wilson, R., Peters, A., Winkelmann, J., Chambers, J. C., Chow, V. T. K., Khor, C. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16841292
Gomes, M. B., Santos, D. C., Drummond, K. R. G., Pinheiro, A., Muniz, L. H., Leal, F. S. L., & Negrato, C. A. (2024) · Figshare · doi:10.6084/m9.figshare.26570878
Dsouza, J. J., Katalkar, P., Mishra, S., & Gaba, Y. A. (2026) · Wisdom Management Journal · doi:10.64848/wjst.2.1.2026.24-28
Tundidor, D., Blanco, J., Cañizares, S., Seguí, N., Obach, A., Molero, J., Conget, I., Giménez, M., Vidal, J., & Flores, L. (2026) · International Journal of Obesity · doi:10.1038/s41366-026-02147-7
Kaur, M. K. K., MD, D. G. A., & MD, D. M. S. (2024) · Obesity Research - Open Journal · doi:10.17140/oroj.2024.v10.i01.pp01-05.1518
Metadata
- Authors
- Polsky, S., & Ellis, S. L.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Polsky, Sarit
- ORCID
- Polsky, Sarit
- Venue
- Current Opinion in Endocrinology, Diabetes & Obesity
- Published
- 2015-08
- Volume
- 22
- Issue
- 4
- Pages
- 277-282
- ISSN
- 1752-296X (ISSN-L)
- OpenAlex
- W2184822581
- Cited by
- 235
- References
- 27
- Citations by year
- 2026: 5 · 2025: 16 · 2024: 29 · 2023: 21 · 2022: 35 · 2021: 27 · 2020: 26 · 2019: 23 · 2018: 21 · 2017: 18 · 2016: 10 · 2015: 4
- FWCI
- 15.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Opinion in Endocrinology Diabetes and Obesity (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 1 diabetes, obesity, insulin resistance, childhood obesity, metabolic syndrome, microvascular complications, macrovascular complications, metformin, biguanides, GLP-1 receptor agonists, exenatide, SGLT2 inhibitors, bariatric surgery
- MeSH terms
- Diabetes Mellitus, Type 1, Humans, Insulin Resistance, Obesity, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
